Here is what the company publishes, along with broader market context
It is involving the endocrine cells of the gastrointestinal tract and their action as a possible therapeutic target for Type 2 Diabetes Mellitus due to their activation of GLP-1, which results in a hypoglycemic impact [17]
Interactions with supplements and herbal preparations should also be considered when using Semaglutide / Cyanocobalamin Injection
In addition to significant weight loss, Wegovy is the only GLP-1 for adults with obesity that is proven to reduce the risk of events such as stroke, heart attack, or cardiovascular death in those who also have known heart disease, said Jamey Millar, the executive vice president of Novo Nordisks US operations
With high-purity peptides from a source like Real Peptides, this should never be a problem
In a written statement, Novo Nordisk, the manufacturer of Ozempic and Wegovy, said patient safety is its top priority